Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
- 1 March 2010
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 375 (9717), 816-823
- https://doi.org/10.1016/s0140-6736(09)62163-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysisThe Lancet, 2009
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised studyThe Lancet, 2009
- Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical TrialJNCI Journal of the National Cancer Institute, 2008
- A Study of Sexuality and Health among Older Adults in the United StatesThe New England Journal of Medicine, 2007
- Tutorial in biostatistics: competing risks and multi‐state modelsStatistics in Medicine, 2006
- Geographic and temporal variations in cancer of the corpus uteri: Incidence and mortality in pre- and postmenopausal women in EuropeInternational Journal of Cancer, 2005
- Stage II endometrial carcinoma: Limiting post-operative radiotherapy to the vaginal vault in node-negative tumorsGynecologic Oncology, 2005
- A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group studyGynecologic Oncology, 2004
- Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinomaCancer, 2004
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003